Published in Lab Business Week, August 29th, 2004
Notable in the revised labeling is the demonstrated performance longevity of the Novacor LVAS, which encompasses implant duration from 0 to more than 36 months.
The revised labeling, which is based upon statistical analysis of 1077 device implants, shows the chance for re-operation to either fix or replace the Novacor LVAS is 1.6% between 0 and 6...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.